Suppr超能文献

探索系统性红斑狼疮与2019冠状病毒病之间的复杂关系:遗传学见解与潜在保护机制。

Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.

作者信息

Xu Xiaoli, Chen An-Tian, Ding Yantao, Zhu Tingting, Xia Luyao, Xu Jingkai, Sun Liyue, Liu Lu

机构信息

Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.

出版信息

J Glob Health. 2025 Jul 11;15:04191. doi: 10.7189/jogh.15.04191.

Abstract

BACKGROUND

Severe coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE) have been reported to share common gene loci, but the causal relationship between them remains controversial.

METHODS

We conducted a linkage disequilibrium score regression analysis to assess the genetic correlations between SLE and the two traits (infection and severity) of COVID-19 in European populations. Mendelian randomisation analysis was then performed to explore the causal effect of SLE on susceptibility to these traits in both European and East Asian data sets. Lastly, enrichment analysis and Protein-Protein Interactions analysis were used to identify key pathways and genes involved, providing insights into the possible mechanism underlying the complex relationship between SLE and COVID-19.

RESULTS

A significant genetic correlation was observed between SLE and COVID-19 severity (genetic correlation (rg) = 0.340, P = 0.001). However, no significant genetic correlation was found with COVID-19 infection. Mendelian randomisation analysis revealed a negative causal effect of SLE on both COVID-19 infection (odds ratio (OR) = 0.986; 95% confidence interval (CI) = 0.975-0.997, P = 0.009) and severity (OR = 0.955; 95% CI = 0.921-0.990, P = 0.012) in European populations, with similar findings replicated in East Asians. Notably, interleukin-6 (IL-6) and tumour necrosis factor were identified as hub cytokines connecting SLE to COVID-19 infection, while IL-6 and interleukin-10 (IL-10) were pivotal in connecting SLE to COVID-19 severity.

CONCLUSIONS

This study reveals a potentially protective effect of SLE against COVID-19 infection and severity, with IL-6, tumour necrosis factor, and IL-10 playing key roles. Despite immunosuppressant use, SLE patients showed no increased risk of severe outcomes, likely due to their heightened caution in avoiding infection. These findings challenge common assumptions and highlight the need for further research.

摘要

背景

据报道,2019年冠状病毒病(COVID-19)重症病例与系统性红斑狼疮(SLE)存在共同的基因位点,但两者之间的因果关系仍存在争议。

方法

我们进行了连锁不平衡评分回归分析,以评估欧洲人群中SLE与COVID-19的两个特征(感染和严重程度)之间的遗传相关性。随后进行孟德尔随机化分析,以探究SLE对欧洲和东亚数据集里这些特征易感性的因果效应。最后,利用富集分析和蛋白质-蛋白质相互作用分析来识别相关关键途径和基因,从而深入了解SLE与COVID-19之间复杂关系的潜在机制。

结果

观察到SLE与COVID-19严重程度之间存在显著的遗传相关性(遗传相关性(rg)=0.340,P=0.001)。然而,未发现与COVID-19感染存在显著的遗传相关性。孟德尔随机化分析显示,在欧洲人群中,SLE对COVID-19感染(优势比(OR)=0.986;95%置信区间(CI)=0.975-0.997,P=0.009)和严重程度(OR=0.955;95%CI=0.921-0.990,P=0.012)均有负面因果效应,东亚人群也有类似发现。值得注意的是,白细胞介素-6(IL-6)和肿瘤坏死因子被确定为连接SLE与COVID-19感染的枢纽细胞因子,而IL-6和白细胞介素-10(IL-10)在连接SLE与COVID-19严重程度方面起关键作用。

结论

本研究揭示了SLE对COVID-19感染和严重程度可能具有保护作用,IL-6、肿瘤坏死因子和IL-10发挥了关键作用。尽管使用了免疫抑制剂,但SLE患者出现严重后果的风险并未增加,这可能是因为他们在避免感染方面更加谨慎。这些发现挑战了常见假设,凸显了进一步研究的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/431b/12247663/bb84a15f4434/jogh-15-04191-F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验